Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 689 of 767

Advanced search

🌍Apr 13Industrynervgen.comTier 1 · Company source

NervGen Pharma to Participate in the H.C. Wainwright “HCW@Home” Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference

NervGen PharmaOriginal source

🌍Apr 13Industryfidson.comTier 1 · Company source

IMPROVING EYE CARE IN AFRICA: INTRODUCING ATROPINE 1% EYE DROP FROM FIDSON’S AVENTRA PROVISION

Fidson HealthcareOriginal source

🇫🇷Apr 13Industrycellectis.comTier 1 · Company source

Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform

CellectisOriginal source

🇮🇹Apr 13Mediamg2.itTier 2 · Direct publisher

MG2 a interpack 2026 con le opercolatrici della Serie E

MG2 s.r.l.Original source

🇮🇹Apr 13Mediamg2.itTier 2 · Direct publisher

MG2 at interpack 2026 with the E Series capsule fillers

MG2 s.r.l.Original source

🇯🇵Apr 13Devicessysmex.co.jpTier 1 · Company source

Sysmex Launches an Assay Kit for Identifying p-Tau217 in the Blood, a Biomarker Related to Alzheimer's Disease

Sysmex (Global)Original source

🇯🇵Apr 13Devicessysmex.co.jpTier 1 · Company source

Sysmex to Serve as Special Sponsor of Kobe Marathon 2026 â Supporting the Event Toward a Healthy, Prosperous Society and Vibrant Local Communities â

Sysmex (Global)Original source

🇺🇸Apr 13Researchnewsroom.clevelandclinic.orgTier 2 · Direct publisher

Young Girl with Autism Finds Voice Thanks to Therapy

Cleveland Clinic Main CampusOriginal source

🇺🇸Apr 12Researcharchventure.comTier 2 · Direct publisher

The San Francisco Business Times honors ARCH’s Carol Suh on 40 Under 40 Class of 2026

ARCH Venture PartnersOriginal source

🇲🇽Apr 11Researchsecihti.mxTier 3 · Secondary coverage

Policy Briefs VI serie 2

CONACYT NewsOriginal source

🇲🇽Apr 11Researchsecihti.mxTier 3 · Secondary coverage

Policy Briefs V serie 2

CONACYT NewsOriginal source

🇲🇽Apr 11Researchsecihti.mxTier 3 · Secondary coverage

Policy Briefs lV serie 2

CONACYT NewsOriginal source

🇲🇽Apr 11Researchsecihti.mxTier 3 · Secondary coverage

Policy Briefs III serie 2

CONACYT NewsOriginal source

🇲🇽Apr 11Researchsecihti.mxTier 3 · Secondary coverage

Policy Briefs II serie 2

CONACYT NewsOriginal source

🇲🇽Apr 11Researchsecihti.mxTier 3 · Secondary coverage

Policy Briefs l serie 2

CONACYT NewsOriginal source

🇮🇳Apr 11Researchhome.iitd.ac.inTier 2 · Direct publisher

Geliose Mobility, an IIT Delhi incubated startup, launches ‘HOPE’, an affordable electric scooter for last mile delivery and personal commute

IIT Delhi BiosciencesOriginal source

🇺🇸Apr 11Industryadaptivebiotech.comTier 1 · Company source

Predicting T Cell Recognition: New Insights from Large-Scale Activation Data

A study accepted to ML4H 2025 explores whether sequence-based models trained on large-scale T-cell a...

Adaptive BiotechnologiesOriginal source

🇺🇰Apr 10Researchuclh.nhs.ukTier 2 · Direct publisher

Improving care and outcomes for HLH patients

University College London Hospitals (UCLH)Original source

🇺🇸Apr 10Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002)

PubMed Journal of Clinical Oncology RSSOriginal source

🇺🇰Apr 10Industryastrazeneca.comTier 1 · Company source

Alexion data at 2026 AAN Annual Meeting reflects industry-leading portfolio and commitment to enhancing care across rare diseases

AstraZeneca RSSOriginal source

🌍Apr 10Industryzevra.comTier 1 · Company source

Analysis of NPC1 Genotypes: Findings From the US Arimoclomol Expanded Access Program for Niemann-Pick Disease Type C

Zevra TherapeuticsOriginal source

🇯🇵Apr 10Industryshionogi.comTier 1 · Company source

Shionogi Selected as a “DX Stock 2026”

The DX Stock program evaluates and selects companies that are transforming their business models and...

ShionogiOriginal source

🇫🇮Apr 10Industryorionpharma.comTier 1 · Company source

Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 20264/10/2026 Press release

ORION CORPORATION PRESS RELEASE 10 APRIL 2026 at 9.00 EEST Orion publishes Interim Report for Januar...

Orion CorporationOriginal source

🇨🇭Apr 10Industryidorsia.comTier 1 · Company source

Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders

IdorsiaOriginal source

🇺🇸Apr 10Industrynewsroom.viatris.comTier 1 · Company source

Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Mylan (Viatris)Original source

🇺🇸Apr 10Industryir.vikingtherapeutics.comTier 1 · Company source

Viking Therapeutics to Participate at Upcoming Investor Conferences

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focu...

Viking TherapeuticsOriginal source

🇺🇸Apr 10Industryir.ideayabio.comTier 1 · Company source

IDEAYA Biosciences to Announce Topline Results from Phase 2/3 OptimUM-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company, today announced plan...

IDEAYA BiosciencesOriginal source

🇺🇸Apr 10Researchbroadinstitute.orgTier 2 · Direct publisher

Leukemia cells use a sugar-coated protein to hide from the immune system

Broad Institute NewsOriginal source

🌍Apr 9Researchunityhealth.toTier 2 · Direct publisher

How this Unity Health information specialist makes knowledge accessible for staff

St. Michael's Hospital (Toronto)Original source

🇺🇸Apr 9Devicesviz.aiTier 1 · Company source

Viz.ai Earns Back-to-Back No. 1 Ranking in Black Book Survey of AI Clinical Decision Support Solutions

Viz.aiOriginal source

🌍Apr 9CROtrinetx.comTier 2 · Direct publisher

Strengthening Muscle-Invasive Bladder Cancer Care: The Untapped Potential of Perioperative Systemic Therapy

TriNetXOriginal source

🇯🇵Apr 9Devicesglobal.medical.canonTier 1 · Company source

Canon launches Ultimion, Japan’s first domestically produced Photon-Counting CT

Canon Medical SystemsOriginal source

🇺🇸Apr 9Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Targeted therapy in early-stage classical Hodgkin lymphoma

PubMed Blood RSSOriginal source

🇯🇵Apr 9Devicesolympus-global.comTier 1 · Company source

Update: IR Library "Olympus Business"

Olympus MedicalOriginal source

🌍Apr 9Industryzentiva.comTier 1 · Company source

GTCR Completes Acquisition of Zentiva

Zentiva (Global)Original source

🌍Apr 9Regulatorywho.intTier 1 · Regulatory source

9 April 2026Departmental updateKazakhstan becomes first country in Central Asia to earn WHO recognition for regulation of medicines and imported vaccines

Kazakhstan has achieved a major public health milestone, becoming the first country in Central Asia...

World Health Organization (WHO)Original source

🇺🇸Apr 9Researchurmc.rochester.eduTier 2 · Direct publisher

When Should I Get LASIK? Age, Eligibility, and Recovery Explained

Is there a best age or time for LASIK? UR Medicine eye doctors explain eligibility, recovery, and ho...

University of RochesterOriginal source

🇫🇮Apr 9Industryorionpharma.comTier 1 · Company source

Orion’s production processes in Turku, Finland to become carbon free with new steam plant4/9/2026 Sustainability

Orion has commissioned a new steam plant at its Turku factory, as a result of which the site's pharm...

Orion CorporationOriginal source

🇨🇭Apr 9Industryidorsia.comTier 1 · Company source

Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development

IdorsiaOriginal source

🇩🇪Apr 9Industryir.imux.comTier 3 · Secondary coverage

Immunic to Participate in Scientific and Medical Conferences in April

Stay informed with Immunic’s latest press releases covering corporate updates, preclinical and clini...

ImmunicOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

Blaine Labs, Inc Issues Voluntary Nationwide Recall of Wound Care Gel Products Due to Microbial Contamination

Santa Fe Springs, California – April 07, 2026 – Blaine Labs, Inc. is voluntarily recalling three (3)...

FDA Drug ApprovalsOriginal source

🇫🇷Apr 9Industrytransgene.comTier 1 · Company source

Investor Access Event (Paris, France)

TransgeneOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

Patient Listening Session Summaries

Patient Listening Session summaries are published after each session to share a high-level summary o...

FDA CBER (Biologics)Original source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA approves safety labeling changes for opioid pain medicines

Today, FDA is announcing final approval and immediately effective implementation of required labelin...

FDA Drug ApprovalsOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain

FDA continues to investigate counterfeit Ozempic (semaglutide) injection 1 milligram (mg) in the leg...

FDA Drug ApprovalsOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA's ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital health technology for neuroscience

FDA's Center for Drug Evaluation and Research (CDER) recently accepted a new submission into the Inn...

FDA Drug ApprovalsOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA revises letter of authorization for the emergency use authorization for Paxlovid

FDA Drug ApprovalsOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA issues guidance regarding drug development for early Alzheimer’s disease

FDA Drug ApprovalsOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA Announces New Quality Oversight Webpage

FDA Drug ApprovalsOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA establishes CDER Center for Clinical Trial Innovation (C3TI)

FDA establishes CDER Center for Clinical Trial Innovation (C3TI), which will promote CDER clinical t...

FDA Drug ApprovalsOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA issues agency-initiated proposed order regarding OTC monograph drugs containing acetaminophen

Today, FDA issued a proposed administrative order, to address a safety issue related to over-the-cou...

FDA Drug ApprovalsOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA updates guidance on interchangeability

FDA issued a draft guidance for industry “Considerations for Demonstrating Interchangeability with a...

FDA Drug ApprovalsOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA's ISTAND Pilot Program accepts a submission of first organ-on-a-chip technology designed to predict human drug-induced liver injury (DILI)

FDA accepts first letter of intent (LOI) into the ISTAND Pilot Program for an organ-on-a-chip techno...

FDA Drug ApprovalsOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize

The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucag...

FDA Drug ApprovalsOriginal source

🇺🇸Apr 9Regulatoryfda.govTier 1 · Regulatory source

FDA approves REMS modification, advancing new drug disposal option

FDA approves risk evaluation and mitigation strategy (REMS) modification, advancing new drug disposa...

FDA Drug ApprovalsOriginal source

🌍Apr 9Mediarhoworld.comTier 2 · Direct publisher

The Acute Pain Uncertainty Principle

RhoOriginal source

🌍Apr 8CROtrinetx.comTier 2 · Direct publisher

How Taichung Veterans General Hospital is Advancing Real-World Evidence Research with TriNetX

TriNetXOriginal source

🇩🇪Apr 8Researchuk-essen.deTier 2 · Direct publisher

4. Onko-Talk zu „Hightech-Medizin bei Lungenkrebs“

Universitätsklinikum EssenOriginal source

🇺🇸Apr 8Researchpenntoday.upenn.eduTier 2 · Direct publisher

Shujie Yang harnesses sound to build the next generation of microrobotic medicine

Yang’s lab at Penn Engineering uses precisely-controlled ultrasound waves to develop microscale tool...

University of PennsylvaniaOriginal source

🇺🇸Apr 8Industryinvestor.precisionbiosciences.comTier 1 · Company source

Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference

Precision BioSciencesOriginal source

Pharmaceutical industry news

NervGen Pharma to Participate in the H.C. Wainwright “HCW@Home” Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference

IMPROVING EYE CARE IN AFRICA: INTRODUCING ATROPINE 1% EYE DROP FROM FIDSON’S AVENTRA PROVISION

Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform

MG2 a interpack 2026 con le opercolatrici della Serie E

MG2 at interpack 2026 with the E Series capsule fillers

Sysmex Launches an Assay Kit for Identifying p-Tau217 in the Blood, a Biomarker Related to Alzheimer's Disease

Sysmex to Serve as Special Sponsor of Kobe Marathon 2026 â Supporting the Event Toward a Healthy, Prosperous Society and Vibrant Local Communities â

Young Girl with Autism Finds Voice Thanks to Therapy

The San Francisco Business Times honors ARCH’s Carol Suh on 40 Under 40 Class of 2026

Policy Briefs VI serie 2

Policy Briefs V serie 2

Policy Briefs lV serie 2

Policy Briefs III serie 2

Policy Briefs II serie 2

Policy Briefs l serie 2

Geliose Mobility, an IIT Delhi incubated startup, launches ‘HOPE’, an affordable electric scooter for last mile delivery and personal commute

Predicting T Cell Recognition: New Insights from Large-Scale Activation Data

Improving care and outcomes for HLH patients

Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002)

Alexion data at 2026 AAN Annual Meeting reflects industry-leading portfolio and commitment to enhancing care across rare diseases

Analysis of NPC1 Genotypes: Findings From the US Arimoclomol Expanded Access Program for Niemann-Pick Disease Type C

Shionogi Selected as a “DX Stock 2026”

Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 20264/10/2026 Press release

Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders

Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Viking Therapeutics to Participate at Upcoming Investor Conferences

IDEAYA Biosciences to Announce Topline Results from Phase 2/3 OptimUM-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026

Leukemia cells use a sugar-coated protein to hide from the immune system

How this Unity Health information specialist makes knowledge accessible for staff

Viz.ai Earns Back-to-Back No. 1 Ranking in Black Book Survey of AI Clinical Decision Support Solutions

Strengthening Muscle-Invasive Bladder Cancer Care: The Untapped Potential of Perioperative Systemic Therapy

Canon launches Ultimion, Japan’s first domestically produced Photon-Counting CT

Targeted therapy in early-stage classical Hodgkin lymphoma

Update: IR Library "Olympus Business"

GTCR Completes Acquisition of Zentiva

9 April 2026Departmental updateKazakhstan becomes first country in Central Asia to earn WHO recognition for regulation of medicines and imported vaccines

When Should I Get LASIK? Age, Eligibility, and Recovery Explained

Orion’s production processes in Turku, Finland to become carbon free with new steam plant4/9/2026 Sustainability

Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development

Immunic to Participate in Scientific and Medical Conferences in April

Blaine Labs, Inc Issues Voluntary Nationwide Recall of Wound Care Gel Products Due to Microbial Contamination

Investor Access Event (Paris, France)

Patient Listening Session Summaries

FDA approves safety labeling changes for opioid pain medicines

FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain

FDA's ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital health technology for neuroscience

FDA revises letter of authorization for the emergency use authorization for Paxlovid

FDA issues guidance regarding drug development for early Alzheimer’s disease

FDA Announces New Quality Oversight Webpage

FDA establishes CDER Center for Clinical Trial Innovation (C3TI)

FDA issues agency-initiated proposed order regarding OTC monograph drugs containing acetaminophen

FDA updates guidance on interchangeability

FDA's ISTAND Pilot Program accepts a submission of first organ-on-a-chip technology designed to predict human drug-induced liver injury (DILI)

FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize

FDA approves REMS modification, advancing new drug disposal option

The Acute Pain Uncertainty Principle

How Taichung Veterans General Hospital is Advancing Real-World Evidence Research with TriNetX

4. Onko-Talk zu „Hightech-Medizin bei Lungenkrebs“

Shujie Yang harnesses sound to build the next generation of microrobotic medicine

Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference

Sysmex to Serve as Special Sponsor of Kobe Marathon 2026 â Supporting the Event Toward a Healthy, Prosperous Society and Vibrant Local Communities â